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doi:10.1016/j.kjms.2011.11.017Abstract Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited
cancer syndrome that expresses nonendocrine and endocrine tumors. Here, we describe
a 42-year-old man with an initial presentation of low back pain and hypertension. Clinical
assessments revealed pheochromocytoma, medullary thyroid carcinoma with bone metastasis,
and parathyroid hyperplasia. MEN 2A was diagnosed, and a family history of pheochromocy-
toma was traced. Surgical resection of the pheochromocytoma of the adrenal gland resulted
in a cure of the patient’s hypertension. He received systemic chemotherapy with the “MAID”
regimen (mesna, doxorubicin, ifosfamide, and dacarbazine) over three cycles of 3 weeks each,
and showed a partial response.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Multiple endocrine neoplasia (MEN) is an autosomal domi-
nant inherited cancer syndrome with a prevalence rate of
2.5 per 100,000 individuals in the general population [1].
MEN type 2 comprises medullary thyroid carcinoma, pheo-
chromocytoma, and parathyroid hyperplasia or adenoma. A
mutation in the RET proto-oncogene, which encodes
a tyrosine receptor, is associated with the MEN 2 family [1].
Wepresent the caseof a 42-year-oldmalepatientwhohad
MEN 2A and a family history that contributed to theedicine, College of Medicine,
h Chuan 1st Road, Kaohsiung
(S.-F. Lin).
vier Taiwan LLC. All rights reservdevelopment of the syndrome. His mother had a history of
pheochromocytomas and a thyroid tumor of unknown cell
type. Surgical resection of the pheochromocytoma in the
patient’s adrenal gland resulted in a cure of his hypertension.
He received systemic chemotherapywith the“MAID” regimen
(mesna, doxorubicin, ifosfamide, and dacarbazine) over
three cycles of 3 weeks each, and showed a partial response.
Case report
A 42-year-old man who had had chronic hepatitis B and
hypertension for 10 years presented with low back pain,
which he had been experiencing for 1 week, accompanied
by weight loss of 3e5 kg over the preceding 2 months,
headache, and paradoxical sweating. His baseline blood
pressure was 200/100 mmHg.ed.
Figure 1. Magnetic resonance imaging (MRI) of the spine
showed multiple metastases within the vertebral bodies of the
T8eL5 vertebrae, spinous processes, sacrum, and iliac bones.
342 C.-T. Huang et al.Because of the low back pain, he underwent spine
radiography, which revealed a compression fracture from
T12 to L2, and magnetic resonance imaging of the spine
showed multiple metastases within the vertebral bodies of
the T8eL5 vertebrae, spinous processes, sacrum, and iliac
bones (Fig. 1). The initial laboratory findings are shown in
Table 1.
Abdominal echo revealed a left adrenal mass
(4.8 cm  5.1 cm; Fig. 2A). The computed tomography scanTable 1 Results of laboratory tests.
Variable Referenc
Hematocrit (%) 41.5e50 (m
Hemoglobin (g/dL) 14e17.5 (m
White cell count (/mm3) 4,400e11,3
Platelet count (/mm3) 172,000e4
Vanillylmandelic acid (mg/24 h) <6
Calcitonin (pg/mL) <12
Parathyroid hormone (pg/mL) 11e54
Iron calcium (mg/dL) 4.6e5.2
Phosphate (mg/dL) 2.5e4.6
Blood urea nitrogen(mg/dl)/creatinine (mg/dl) 8e20/0.6e
GOT/GPT (IU/L) 10e40
Sodium (mmol/L) 136e144
Potassium (mmol/L) 3.5e5.1
GOT Z aspartate aminotransferase; GPT Z alanine aminotransferaseof the abdomen showed a left adrenal mass (4.8cm  5.1
cm), which showed the same lesion compatible with
abdominal echo finding. (Fig. 2B). Thyroid ultrasonography
revealed a multinodular goiter; the right side of the thyroid
gland measured 1.2 cm  0.6 cm (Fig. 3A) and the left side
4.6 cm  1.98 cm (Fig. 3B). Because of hypertension asso-
ciated with the left-sided adrenal tumor mass, we con-
sulted a urologist to debulk the left-sided adrenal gland
tumor.
Pathological analysis of the adrenal gland tumor showed
a “ball in the hole”-like tumor nest separated by epithelial
cells or a trabecular architecture, which is known as
a zellballen arrangement [2] and is characteristic of
pheochromocytomas (Fig. 4A). Furthermore, immunohisto-
chemical studies showed positivity for chromogranin A
(Fig. 4B). The patient underwent total thyroidectomy, and
pathological analysis of the thyroid tumor showed round to
oval-shaped tumor cells with a salt and pepper-like
appearance (Fig. 4C). Immunohistochemical studies also
showed positivity for calcitonin (Fig. 4D).
The patient received a thoracic spine (T spine) bone
biopsy, which showed the presence of a thyroid tumor (data
not shown) characteristic of medullary thyroid carcinoma.
The parathyroid gland showed mild hyperplasia (data not
shown). Taken together, the patient presented with
evidence of medullary thyroid carcinoma with bone
metastasis, primary hyperparathyroidism, and pheochro-
mocytoma, and the diagnosis was MEN 2A.
Surgical resection of the pheochromocytoma in the left-
sided adrenal gland resulted in a cure of the patient’s
hypertension. He received systemic chemotherapy with the
“MAID” regimen (mesna, doxorubicin, ifosfamide, and
dacarbazine) over three cycles of 3 weeks each, and
showed a partial response. The patient’s hypertension and
vanillylmandelic acid levels recovered to normal ranges.
The laboratory of calcitonin showed a partial response
(Table 1).
Discussion
MEN 2 is a rare autosomal dominant disease. In an original
article describing MEN 2A patients, the prognosis of thise range Initial laboratory Post chemotherapy
ale) 45 43
ale) 14.1 13
00 (male) 13,370 8,000
50,000 279000 260,000
25.1 <5
606.3 300
66 50
5.5 4.8
2.4 3.1
1.3 14.1/0.6 15/0.8
48/50 44/48
137 130
4.5 4.2
.
Figure 2. (A) Abdominal echo revealed a left adrenal mass (4.8  5.1 cm). (B) Computed tomography (CT) scan of the abdomen
showed the same lesion.
Figure 4. (A) Pathological analysis of the adrenal gland tumor showed a ball-in-hole-like tumor nest that was separated by
epithelium cells or trabecular architecture, which is known as the “zellballen arrangement” and is characteristic of pheochro-
mocytoma with vascular permeation. (B) Immunohistochemical studies of the adrenal gland tumor showed positivity for
chromogranin-A. (C) Pathological analysis of the thyroid tumor showed round-to-oval-shaped tumor cells with salt- and pepper-like
appearance. (D) Immunohistochemical studies of the thyroid tumor showed positivity for calcitonin.
Figure 3. (A) Thyroid ultrasonography showed right-side tumor mass (1.2  0.6 cm). (B) Thyroid ultrasonography showed
left-side tumor mass (4.6  1.98 cm).
Multiple endocrine neoplasia 343
344 C.-T. Huang et al.mutation in Cys codons 609, 611, 618, 620, and 634 was
discussed [3]. Early diagnosis by screening family members
for MEN 2A kindreds is essential because medullary thyroid
carcinoma is a life-threatening disease that can be cured or
prevented by performing early thyroidectomy [3].
Marijuan et al. discussed prophylactic thyroidectomy for
patients with MEN 2A who were screened for RET mutations
[4]. We reviewed the efficacy of systemic chemotherapy for
advanced medullary thyroid carcinoma [5e8]. All of the
regimens achieved a partial response, but complete
remission was achieved in only a few cases. Alternative
treatments included the administration of biologic modi-
fiers and radioimmunotherapy [9].
The patient described here received systemic chemo-
therapy with the “MAID” over three cycles of 3 weeks each,
and obtained a partial response. After debulking of the
pheochromocytoma in the left-sided adrenal gland, the
patient’s hypertension and vanillylmandelic acid level
recovered to normal ranges, and the laboratory calcitonin
result showed a partial response.
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